Arrhythmias & electrophysiology

Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: The LAMP-AF study

Heart RhythmPublished Consecutive adults undergoing de novo left atrial (LA) ablation for atrial fibrillation (AF) were enrolled, with repeat ablation cases analyzed

Authors' conclusion

LA myopathy advances in one-third of repeat AF ablation patients without chamber enlargement, exhibiting heterogeneous progression favoring septal, anterior, and posterior segments while sparing the lateral wall. Baseline CV and LA volume robustly predict LVA progression, indicating functional electrical remodeling precedes structural fibrosis, highlighting the importance of integrating functional markers when characterizing atrial substrate progression.

Study context

Population
Adults undergoing de novo left atrial ablation for AF who had repeat ablation
Participants
90 repeat ablation patients
Exposure
Patients with vs without LVA progression; predictors of progression and of AF recurrence
Outcome
Total LVA
Follow-up
Baseline to repeat procedure
Methodological detailslongitudinal
  • Longitudinal

Main finding

As reported in the abstract

Total LVA increased from
9.5 ± 16.8% to 19.0 ± 24.7%
P
P < .001

Observational data: associations, not effects.

Further findings

12-month AF recurrence predicted by LVA burden

EstimateP value
LVA burden (baseline)Baselineodds ratio 3.65 per 1%P = 0.049
LVA burden (second procedure)At second procedureodds ratio 2.54P = 0.012
OutcomeProgressionNo progression
Baseline characteristics by progression
CHA2DS2-VASc2.752.05
LA volume152 mL122 mL
Baseline CV0.86 m/s1.02 m/s
  • Baseline characteristics by progression: CHA2DS2-VASc P = .021
  • Baseline characteristics by progression: LA volume P = .008
  • Baseline characteristics by progression: Conduction velocity (CV) P = .013

Patients with >10% LVA progression

Patients with >10% progression
33%
Septal
42%
Anterior
37%
Posterior
34%

Multivariable predictors of progression

Baseline LA volume
P = 0.002
CV
P = 0.043
R2
0.206

Original publication

Left atrial myopathy development and progression in atrial fibrillation patients with recurrent left atrial ablation procedures: The LAMP-AF study. Heart Rhythm. Published 5 May 2026. doi:10.1016/j.hrthm.2026.04.056

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.